Chatsworth, California (PRWEB) July 11, 2013
Cavitation Technologies, Inc. announced today that the Company will commence trial testing of it’s Cavitation Electrocoagulation System with several “frack water” and wastewater treatment facilities within the U.S.
CTi’s Electrocoagulation System provides an innovative and efficient solution for the treatment of wastewater. More importantly, because of the system’s low electricity requirements and miniaturization of needed power supplies, the system can dramatically reduce operating costs compared to conventional wastewater treatment methods.
Roman Gordon, the company’s CTO, added, “Our Cavitation waste water system has demonstrated it can dramatically minimize the presence of heavy metals, oil emulsions, fats, grease, bacteria, viruses, and cysts in an environmentally sound and cost-effective manner. Our Cavitation technology and Electrocoagulaiton process provides the opportunity to maximize the beneficial re-use of resource materials, minimize transportation and disposal costs, as well as their associated liabilities.”
Additionally, Gordon noted that the potential applications of CTi’s system are infinite, as waste water treatment plays a vital role in food, beverage, pharmaceutical, pulp and paper, textiles, manufacturing, marine industry, mining process water, municipal water management, and automotive uses. The Company plans to begin utilizing the system in fiscal 2014 and will identify strategic partners accordingly.
Founded in 2007, the company designs and manufactures state-of-the-art, flow-through, robust devices and systems and develops processing technologies for use in edible oil refining, renewable fuel production, expeditious petroleum upgrading, algal oil extraction, alcoholic beverage enhancement and water treatment. As an add-on to existing neutralization systems, the company’s patented NanoReactor™ allows refiners
Copyright©2012 Vocus, Inc.
All rights reserved